NanoViricides is trading at $1.56 (5.2% up) in after-hours trading, rebounding from a 10.5% drop earlier on July 24 to $1.37 with no clear news catalyst.
- The move appears stock-specific, as there are no fresh company announcements, earnings reports, or regulatory updates available.
- No sector-wide biotech headlines or broader market trends have been identified that directly explain the after-hours strength.